NCT07653490

Brief Summary

This prospective randomized controlled study aims to evaluate the effects of preoperative ultrasound-guided erector spinae plane (ESP) block combined with low-flow anaesthesia on postoperative quality of recovery and opioid consumption in patients undergoing elective laparoscopic cholecystectomy. The study will compare postoperative recovery quality, pain scores, analgesic requirements, and perioperative outcomes between patients receiving ESP block with low-flow anaesthesia and those receiving standard anaesthetic management.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable postoperative-pain

Timeline
12mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 17, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

June 22, 2026

Expected
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2027

Last Updated

June 17, 2026

Status Verified

June 1, 2026

Enrollment Period

11 months

First QC Date

June 4, 2026

Last Update Submit

June 12, 2026

Conditions

Keywords

Erector Spinae Plane BlockLow-Flow AnaesthesiaOpioid ConsumptionEnhanced RecoveryLaparoscopic Cholecystectomy

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery-15 (QoR-15) Score at Postoperative 24 Hours

    Quality of Recovery-15 (QoR-15) Total Score at Postoperative 24 Hours Postoperative recovery quality will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire at 24 hours after surgery. The QoR-15 is a validated patient-reported outcome measure consisting of 15 items that evaluate pain, physical comfort, emotional state, physical independence, and psychological support. Total scores range from 0 to 150, with higher scores indicating better postoperative recovery and a higher quality of recovery.

    Postoperative 24 hours

Secondary Outcomes (5)

  • Numeric Rating Scale (NRS) Pain Score

    PACU, 2, 6, 12, and 24 hours postoperatively

  • Postoperative Shoulder Pain Score

    24 hours postoperatively

  • Total Opioid Consumption During the First 24 Postoperative Hours

    24 hours postoperatively

  • Time to First Rescue Analgesic Requirement

    24 hours postoperatively

  • Incidence of Postoperative Nausea and Vomiting (PONV)

    24 hours postoperatively

Study Arms (2)

ESPB + Standard-Flow Anaesthesia

ACTIVE COMPARATOR

Participants will receive a preoperative bilateral ultrasound-guided ESPB with 20 mL of 0.25% bupivacaine on each side at the T7-T8 level, in addition to standard-flow sevoflurane anaesthesia during elective laparoscopic cholecystectomy. Fresh gas flow will be maintained at 3 L/min during the maintenance phase of anaesthesia.

Procedure: Erector Spinae Plane BlockOther: Standard Fresh Gas Flow (3 L/min)Drug: BupivacaineDrug: Sevoflurane

ESPB + Low-Flow Anaesthesia

EXPERIMENTAL

Participants will receive a preoperative bilateral ultrasound-guided ESPB with 20 mL of 0.25% bupivacaine on each side at the T7-T8 level, in addition to low-flow sevoflurane anaesthesia during elective laparoscopic cholecystectomy. Following induction, fresh gas flow will be reduced to 0.5 L/min during the maintenance phase of anaesthesia.

Procedure: Erector Spinae Plane BlockOther: Low Fresh Gas Flow (0.5 L/min)Drug: BupivacaineDrug: Sevoflurane

Interventions

Bilateral ultrasound-guided erector spinae plane block (ESPB) will be performed preoperatively at the T7-T8 level

ESPB + Low-Flow AnaesthesiaESPB + Standard-Flow Anaesthesia

Low-flow anaesthesia will be maintained with sevoflurane using a fresh gas flow rate of 0.5 L/min after the initial high-flow phase following induction of general anaesthesia.

ESPB + Low-Flow Anaesthesia

Standard-flow anaesthesia will be maintained with sevoflurane using a fresh gas flow rate of 3 L/min throughout the maintenance phase of general anaesthesia.

ESPB + Standard-Flow Anaesthesia

Bupivacaine 0.25% will be administered bilaterally during ultrasound-guided erector spinae plane block at the T7-T8 level, with 20 mL injected on each side approximately 30 minutes before surgery.

ESPB + Low-Flow AnaesthesiaESPB + Standard-Flow Anaesthesia

Sevoflurane will be used as the inhalational anaesthetic agent for maintenance of general anaesthesia during elective laparoscopic cholecystectomy. The fresh gas flow rate during maintenance will be determined according to study group allocation.

ESPB + Low-Flow AnaesthesiaESPB + Standard-Flow Anaesthesia

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18-65 years
  • ASA physical status I-II
  • Body mass index (BMI) \<35 kg/m²
  • Scheduled for elective laparoscopic cholecystectomy
  • Ability to provide written informed consent

You may not qualify if:

  • Coagulopathy or bleeding disorders
  • Allergy to local anaesthetic agents
  • Infection at the block application site
  • Neurological or psychiatric disorders
  • Communication difficulties
  • Chronic opioid or analgesic use
  • Reoperation cases
  • Acute cholecystitis
  • Conversion to open surgery
  • Inadequate dermatomal block after ESPB
  • Severe intraoperative hemodynamic instability
  • Intraoperative blood loss ≥250 mL
  • Development of allergic reactions or major complications during follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Doger C, Kahveci K, Ornek D, But A, Aksoy M, Gokcinar D, Katar D. Effects of Low-Flow Sevoflurane Anesthesia on Pulmonary Functions in Patients Undergoing Laparoscopic Abdominal Surgery. Biomed Res Int. 2016;2016:3068467. doi: 10.1155/2016/3068467. Epub 2016 Jun 20.

  • Kutlusoy S, Koca E, Aydin A. Reliability of low-flow anesthesia procedures in patients undergoing laparoscopic cholecystectomy: Their effects on our costs and ecological balance. Niger J Clin Pract. 2022 Nov;25(11):1911-1917. doi: 10.4103/njcp.njcp_387_22.

  • Saleem SZ, Akhtar SMM, Fareed A, Shaik AA, Asghar MS. Redefining pain management: investigating the efficacy and safety of erector spinae plane block and oblique subcostal transversus abdominis plane block in laparoscopic cholecystectomy - a meta analysis of randomized controlled trials. BMC Anesthesiol. 2025 Apr 16;25(1):182. doi: 10.1186/s12871-025-03059-1.

  • Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013 Jun;118(6):1332-40. doi: 10.1097/ALN.0b013e318289b84b.

MeSH Terms

Conditions

Pain, Postoperative

Interventions

BupivacaineSevoflurane

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesMethyl EthersEthersHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbons

Study Officials

  • Leyla SIVACIGIL, MD

    Taksim Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Leyla Sivacigil, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to two parallel groups: an erector spinae plane block (ESPB) plus low-flow anaesthesia group and an ESPB plus standard-flow anaesthesia group. Postoperative quality of recovery, pain scores, and opioid consumption will be compared between the groups in patients undergoing elective laparoscopic cholecystectomy.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2026

First Posted

June 17, 2026

Study Start (Estimated)

June 22, 2026

Primary Completion (Estimated)

May 22, 2027

Study Completion (Estimated)

June 22, 2027

Last Updated

June 17, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared publicly in order to protect participant confidentiality and institutional data privacy policies.